Agoracom: Small Cap Investment - Zenith Epigenetics - ASCO 2019 coming up May 31 to June 4

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

AACR

Topcoin

Mar 30, 2019 06:07AM

Mar 31, 2019 08:05AM

Apr 01, 2019 02:39PM

Re: AACR

tada

Apr 01, 2019 05:52PM

Re: AACR

BearDownAZ

Apr 01, 2019 05:58PM

Re: AACR

tada

Apr 01, 2019 08:25PM

Apr 08, 2019 11:46AM

Apr 09, 2019 11:36AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ASCO 2019 coming up May 31 to June 4

in response to

Re: AACR

BearDownAZ

posted on May 20, 2019 11:08AM

"Perhaps Zenith will present these in more detail at the upcoming American Society for Clinical Oncology (ASCO) meeting May 31 to June 4, 2019? It's on the Zenith schedule of events, but I couldn't find any abstract/presentation listing for Zenith"

As far as I know, all regular abstracts as well as late breaking clinical trial titles are now listed on the ASCO 2019 website. I still haven't seen anything for Zenith or ZEN-3694 on the schedule. Has anyone else found anything? The event is listed on the Zenith events page, but they may just be attending and not presenting.

https://meetings.asco.org/am/program

BearDownAZ

2 Recommendations

Re: ASCO 2019 coming up May 31 to June 4

Nextblockbuster

May 20, 2019 01:34PM

Re: ASCO 2019 coming up May 31 to June 4

BearDownAZ

May 22, 2019 02:51PM

Re: ASCO 2019 coming up May 31 to June 4

KOO-KOO2

May 22, 2019 03:17PM